Company Valuation: Sernova Biotherapeutics Inc

Data adjusted to current consolidation scope
Fiscal Period: October 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 326.4 234.5 243.9 81.33 59.26 43.43 - -
Change - -28.16% 3.99% -66.65% -27.14% -26.71% - -
Enterprise Value (EV) 326.4 234.5 235.1 75.79 63.76 43.43 43.43 43.43
Change - -28.16% 0.27% -67.77% -15.87% -31.89% 0% 0%
P/E -41.7x -8.89x -5.85x -2.5x -3x -4.6x -3.83x -2.3x
PBR - - 18.4x -6.28x -1.96x - - -
PEG - -0x -0.1x 0.1x 0.1x 0.1x -0.2x -0x
Capitalization / Revenue - - - - - - 17.4x 0.34x
EV / Revenue - - - - - - 17.4x 0.34x
EV / EBITDA - - - - - - - -
EV / EBIT -0x -0x -0x -0x -0x -4.72x -3.65x -2.3x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -0.03 -0.09 -0.13 -0.1 -0.05 -0.025 -0.03 -0.05
Distribution rate - - - - - - - -
Net sales 1 - - - - - - 2.5 127.8
EBITDA -6.669 -24.31 -40.06 -31.12 -14.68 - - -
EBIT 1 -6.937 -24.75 -40.5 -31.66 -15.02 -9.2 -11.9 -18.9
Net income 1 -6.966 -24.42 -39 -32.19 -15.74 -11.3 -13.9 -20.9
Net Debt - - -8.722 -5.544 4.503 - - -
Reference price 2 1.2500 0.8000 0.7600 0.2500 0.1500 0.1150 0.1150 0.1150
Nbr of stocks (in thousands) 261,133 293,125 320,857 325,325 395,037 377,643 - -
Announcement Date 2/14/22 1/26/23 1/29/24 12/23/24 12/19/25 - - -
1CAD in Million2CAD
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
-4.6x - - - 30.7M
30.95x4.09x15.82x2.45% 181B
20.26x3.52x12.59x2.99% 116B
22.98x4.5x15.69x1.22% 113B
27.35x2.68x10.75x2.64% 79.83B
18.7x0.22x13.49x0.7% 65.06B
31.17x7.75x19.98x1.28% 54.35B
36.95x3.53x12.1x2.05% 52.23B
37.95x9.42x26.36x-.--% 44.15B
34.57x6.06x19.03x-.--% 32.47B
Average 25.63x 4.64x 16.20x 1.48% 73.86B
Weighted average by Cap. 27.60x 4.20x 15.35x 1.84%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Sernova Biotherapeutics Inc

Historical PBR trend

Valuation ratios - PBR - Sernova Biotherapeutics Inc

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Sernova Biotherapeutics Inc

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Sernova Biotherapeutics Inc

  1. Stock Market
  2. Stocks
  3. SVA Stock
  4. Valuation Sernova Biotherapeutics Inc